Phase III Trial of R21/Matrix-M in African Children Against Clinical Malaria
Condition: Malaria Interventions: Biological: R21/Matrix-M; Biological: Rabies vaccine Sponsors: University of Oxford; Institut de Recherche en Sciences de la Sante - Clinical Research Unit of Nanoro (IRSS-URCN), Nanoro, Burkina Faso; Institut de Recherche en Sciences de la Sante-Direction Regionale de l'Ouest; Malaria Research and Training Center, Bamako, Mali; KEMRI-Wellcome Trust Collaborative Research Program; Ifakara Health Institute Clinical Trial Facility, Bagamoyo Research and Training Centre, PO Box 74, Bagamoyo, Tanzania; London School of Hygiene and Tropical Medicine Not ...
Source: ClinicalTrials.gov - January 12, 2021 Category: Research Source Type: clinical trials
R21/Matrix-M in African Children Against Clinical Malaria
Condition: Malaria Interventions: Biological: R21/Matrix-M; Biological: Rabies vaccine Sponsors: University of Oxford; Institut de Recherche en Sciences de la Sante - Clinical Research Unit of Nanoro (IRSS-URCN), Nanoro, Burkina Faso; Institut de Recherche en Sciences de la Sante-Direction Regionale de l'Ouest; Malaria Research and Training Center, Bamako, Mali; KEMRI-Wellcome Trust Collaborative Research Program; Ifakara Health Institute Clinical Trial Facility, Bagamoyo Research and Training Centre, PO Box 74, Bagamoyo, Tanzania; London School of Hygiene and Tropical Medicine Not ...
Source: ClinicalTrials.gov - January 12, 2021 Category: Research Source Type: clinical trials
Phase III Trial of R21/Matrix-M in African Children Against Clinical Malaria
Condition: Malaria Interventions: Biological: R21/Matrix-M; Biological: Rabies vaccine Sponsors: University of Oxford; Institut de Recherche en Sciences de la Sante - Clinical Research Unit of Nanoro (IRSS-URCN), Nanoro, Burkina Faso; Institut de Recherche en Sciences de la Sante-Direction Regionale de l'Ouest; Malaria Research and Training Center, Bamako, Mali; KEMRI-Wellcome Trust Collaborative Research Program; Ifakara Health Institute Clinical Trial Facility, Bagamoyo Research and Training Centre, PO Box 74, Bagamoyo, Tanzania; London School of Hygiene and Tropical Medicine Not ...
Source: ClinicalTrials.gov - January 12, 2021 Category: Research Source Type: clinical trials
R21/Matrix-M in African Children Against Clinical Malaria
Condition: Malaria Interventions: Biological: R21/Matrix-M; Biological: Rabies vaccine Sponsors: University of Oxford; Institut de Recherche en Sciences de la Sante - Clinical Research Unit of Nanoro (IRSS-URCN), Nanoro, Burkina Faso; Institut de Recherche en Sciences de la Sante-Direction Regionale de l'Ouest; Malaria Research and Training Center, Bamako, Mali; KEMRI-Wellcome Trust Collaborative Research Program; Ifakara Health Institute Clinical Trial Facility, Bagamoyo Research and Training Centre, PO Box 74, Bagamoyo, Tanzania; London School of Hygiene and Tropical Medicine Not ...
Source: ClinicalTrials.gov - January 12, 2021 Category: Research Source Type: clinical trials
A Human Controlled Infection Study With Neisseria Lactamica in Malian Adults
Condition: Meningitis, Meningococcal Intervention: Biological: Intranasal inoculation with Neisseria lactamica Sponsors: Center for Vaccine Development - Mali; University of Southampton; University of Maryland, College Park; University College, London; University of Oxford; Public Health England Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2020 Category: Research Source Type: clinical trials
